Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
488 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00879073 | Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors | terminated | Phase 1 | 12 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00005641 | Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation | terminated | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2012 |
| clinicaltrials |
| NCT00005852 | Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant | terminated | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Dec 11, 2012 | clinicaltrials |
| NCT00006032 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00606008 | A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma | completed | Phase 2 | 30 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 19, 2012 | clinicaltrials |
| NCT00480584 | A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 8, 2012 | clinicaltrials |
| NCT00375024 | Patient Navigator Project | completed | N/A | 1,267 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00104728 | Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates | terminated | N/A | 42 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00005798 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer(CTC) | completed | Phase 2 | 209 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00005622 | Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders | completed | Phase 2 | 72 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 25, 2012 | clinicaltrials |
| NCT00012350 | Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | completed | Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | terminated | Phase 2 | 2 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00031564 | Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 | completed | Phase 2 | 49 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer(ETC) | terminated | Phase 1 / Phase 2 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00006031 | Comparison of Two Types of Biopsy in Patients With Breast Lesions | completed | N/A | 117 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | completed | Phase 1 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00006092 | Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia | terminated | Phase 2 | 2 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00005614 | Management of Metastatic Breast Cancer in Frail Patients | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Sep 25, 2012 | clinicaltrials |
| NCT00005615 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | completed | Phase 1 / Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00005624 | CI-994 in Treating Patients With Advanced Myeloma | completed | Phase 2 | 6 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00005626 | Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) | completed | Phase 2 | 10 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00005640 | Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | completed | N/A | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00005793 | A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | completed | Phase 1 / Phase 2 | 41 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | completed | Phase 2 | 45 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00036686 | Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy | terminated | N/A | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00042731 | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | completed | N/A | 79 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00617617 | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk | completed | Phase 2 | 52 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00798629 | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00434109 | Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | completed | Phase 2 | 39 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00400569 | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma | completed | Phase 2 | 48 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00495625 | Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | terminated | Phase 2 | 33 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00215995 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | completed | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Jan 13, 2012 | clinicaltrials |
| NCT01175278 | Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Jan 12, 2012 | clinicaltrials |
| NCT01175291 | FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Dec 5, 2011 | clinicaltrials |
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine | terminated | Phase 1 / Phase 2 | 11 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00006086 | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer | completed | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00365222 | Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma | terminated | Phase 2 | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00005611 | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Jul 24, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials